NCT07246187
- Conditions
- Cannabinoid Hyperemesis Syndrome, Chemically-Induced Disorders, Marijuana Abuse, +2 more
- Locations
-
- Mercy Saint Vincent Medical Center Toledo, Ohio, United States
Clinical trial condition
Cannabinoid Hyperemesis Syndrome
Explore clinical trials studying Cannabinoid Hyperemesis Syndrome. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Cannabinoid Hyperemesis Syndrome trial results
NCT06660901
- Conditions
- Abdominal Pain, Cannabinoid Hyperemesis Syndrome, Chemically-Induced Disorders, +11 more
- Locations
-
- Angers Centre Hospitalier Universitaire (CHU) Angers, France
- Centre Hospitalier de Cholet Cholet, France
- Centre Hospitalier de Saumur Saumur, France
Enrolling by Invitation
Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
NCT05812339
- Conditions
- Cannabinoid Hyperemesis Syndrome, Chemically-Induced Disorders, Cyclical Vomiting, +15 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada
Not Yet Recruiting
Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department
NCT07726069
- Conditions
- Albinism, Cannabinoid Hyperemesis Syndrome, Chediak-Higashi Syndrome, +15 more
- Locations
-
- University of Illinois Hospital Chicago, Illinois, United States
NCT04283292
- Conditions
- Cannabinoid Hyperemesis Syndrome, Chemically-Induced Disorders, Marijuana Abuse, +2 more
- Locations
-
- UVA Health System Charlottesville, Virginia, United States
Completed
Treatment Strategies in CHS
NCT04176055
- Conditions
- Cannabinoid Hyperemesis Syndrome, Cannabis Hyperemesis Syndrome, Chemically-Induced Disorders, +3 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada